Special Issue: Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress

The provided editorial, “Special Issue: Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress,” explores the dissolving boundaries between neurological and psychiatric disorders at the molecular level. Psychopharmacology’s precise mechanisms of action have revolutionised treatment, but a critical knowledge gap still needs to be addressed. This Special Issue includes five original research articles that aim to elucidate the underlying molecular connections between these interconnected pathologies. For decades, psychological and behavioural therapies have been the foundations of mental health treatment. However, the advent of modern psychopharmacology has profoundly reshaped the therapeutic landscape, integrating medications to address a wide array of psychiatric conditions. Despite these revolutionary advances, a critical challenge remains: the precise mechanisms of action of many pharmacological treatments remain largely unknown. This persistent knowledge gap compels us to explore further.